Stock Ratings / Health Care / ICUI / options

IRTC (48) PLSE (41) NVST (49) HTFL (53) ⌘ Pro Terminal →

ICU Medical Inc. (ICUI) Options Positioning, Max Pain & Unusual Sweeps

$163.78 -2.89% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $162.62

ICU Medical Inc. (ICUI) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $4.22B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ICUI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ICUI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, ICU Medical Inc. (NASDAQ: ICUI) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $163.78 (-2.89% 1D, market cap $4.22B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, ICUI ranks #183 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ICUI compare to IRTC and PLSE in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), ICUI carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of 36.8%, and ROIC of 1.0%. By comparison, IRTC (iRhythm Holdings Inc.) holds a D grade (48/100 RQD, P/E N/A, ROIC -13.5%, cap $4.21B) and PLSE (Pulse Biosciences Inc) posts a D- grade (41/100 RQD, P/E N/A, ROIC -30.7%, cap $3.96B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ICUI?

▼

Per ICUI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000883984), ICU Medical Inc. generated $2.23B in revenue (-6.3% YoY), $732.0K in net income, and $91.8M in free cash flow against $4.05B in total assets and $1.27B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $162.62 (-0.71%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 4.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY • 53.1% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+0.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ICUI)Realized 20D OHLCV Swing Band: ±6.3%

Deterministic 5-Pillar Attribution (59/100 Composite)

🔍 WHY ICUI SCORES 59/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (25% of score)

20D Institutional Volume Accumulation (±6.3% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▼ #1 Drag / Risk Factor: Cash Engine Quality9/20 pts (-11 pt drag)

Capital intensity & 1.9% operating margin leave 11 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$163.91-1.6% Next Q

Q2 (-2Q)

Grade C+$161.24+2.9% Next Q

Q3 (-1Q)

Grade C+$165.96-1.3% Next Q

Current

Grade C-$163.78+0.2% Hist 90D α

Trajectory: B- (67) → C- (59)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ICUI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 59/100 (C-) score, ICUI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($163.94) or 200D SMA ($148.66) invalidates the momentum regime and cuts Target Base ($164.52) toward Bear Floor ($128.33).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ICUI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ICUI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 59%NO 41%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±6.3%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (ICUI)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for ICUI.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating ICUI & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on ICUI
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ICUI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +38.01%🛡️ HOLDING TREND SUPPORT

2026-11-02O $166.4H $168.7L $163.8C $163.8VOL 202.5K

RES: $212.0SUP: $158.4SMA50: $163.9SMA200: $148.7

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ICUI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ICUI Butterfly Map → + Track ICUI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

40.6%/yr Implied 5Y Growth

vs. -6.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ICUI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ICUI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ICUI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ICUI)

Health Care Rank #183 of 1016 ⚔️ IRTC vs ICUI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ICUI vs. IRTC, PLSE, NVST, HTFL)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, ICU Medical Inc. (ICUI) ranks #183 by composite RQD confidence (59/100, grade C-) and #178 by equity capitalization ($4.22B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ICUI currently leads its immediate peer cohort in composite quantitative strength at 59/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ICUI ACTIVE ICU Medical Inc.	C-	59/100	—	36.8%	1.0%	-2.89%	$4.22B	Benchmark Subject
IRTC iRhythm Holdings Inc.	D	48/100	—	70.6%	-13.5%	-3.47%	$4.21B	/irtc-vs-icui →
PLSE Pulse Biosciences Inc	D-	41/100	—	-30.0%	-30.7%	-5.84%	$3.96B	/plse-vs-icui →
NVST Envista Holdings Corporation	D	49/100	84.1x	54.7%	5.1%	-4.47%	$3.95B	/nvst-vs-icui →
HTFL Heartflow Inc.	D+	53/100	—	76.8%	-12.0%	-2.44%	$5.26B	/htfl-vs-icui →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000883984

In its most recent audited fiscal period (FY2025, filed 2025-12-31), ICU Medical Inc. (ICUI) reported GAAP revenue of $2.23B (-6.3% vs. FY2024 revenue of $2.38B , and -1.2% cumulative change since FY2023) , GAAP net income of $732.0K, operating cash flow of $179.8M, and free cash flow of $91.8M (-26.4% YoY). On the balance sheet, ICUI closed FY2025 with $4.05B in total assets against $1.27B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$2.23B	$732.0K	$179.8M	$91.8M	$4.05B	$1.27B
FY2024 (FY)	2024-12-31	$2.38B	-$117.7M	$204.0M	$124.7M	$4.20B	$1.53B
FY2023 (FY)	2023-12-31	$2.26B	-$29.7M	$166.2M	$166.2M	—	—

3. ICUI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ICUI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ICUI compare to IRTC and PLSE in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ICUI?

Where is ICUI trading relative to its 50-day, 200-day, and 52-week technical levels?

ICUI last traded at $163.78 (-2.89% on volume of 216,575 shares), positioning the stock -0.10% below its 50-day simple moving average ($163.94) and +10.17% above its 200-day simple moving average ($148.66). Across its 52-week range of $113.37 to $192.85, ICUI sits at the 63.4% percentile with a 14-day RSI of 56.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±6.3% ($153.46 to $174.10).